E-LIB Suche - Ergebnisse für: R. Moia

1

Clinical utility of circulating tumor DNA qualification and..:

Pirosa, M. C. ; Bruscaggin, A. ; Terzi di Bergamo, L....
Hematological Oncology. 41 (2023) S2 - p. 319-321 , 2023

Link: https://doi.org/10.1002/..

2

MOLECULAR CLUSTERING ON CTDNA IMPROVES THE PROGNOSTIC STRAT..:

Moia, R. ; Talotta, D. ; Dondolin, R....
Hematological Oncology. 41 (2023) S2 - p. 174-175 , 2023

Link: https://doi.org/10.1002/..

3

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BA..:

Pirosa, M. C. ; Bruscaggin, A. ; Terzi di Bergamo, L....
HemaSphere. 6 (2022) - p. 126-127 , 2022

Link: https://doi.org/10.1097/..

4

P1281: LIQUID BIOPSY PROVIDES COMPLEMENTARY INFORMATION TO ..:

Moia, R. ; Favini, C. ; Talotta, D....
HemaSphere. 6 (2022) - p. 1166-1167 , 2022

Link: https://doi.org/10.1097/..

5

CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC ..:

Spina, V. ; Pirosa, M. C. ; Bruscaggin, A....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

6

IBRUTINIB TOLERABILITY AND OUTCOME IN PATIENTS WITH HIGH‐RI..:

Condoluci, A. ; Terzi‐di‐Bergamo, L. ; Forestieri, G....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

7

ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS ..:

Terzi di Bergamo, L ; Forestieri, G ; Loh, J. W...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

8

DISSECTING THE GENETICS OF DIFFERENT ANATOMICAL COMPARTMENT..:

Moia, R. ; Favini, C. ; Ferri, V....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

9

A COMPLETELY GENETIC PROGNOSTIC MODEL OVERCOMES CLINICAL PR..:

Ferrero, S. ; Moia, R. ; Cascione, L....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

10

INTERNATIONAL PROGNOSTIC SCORE FOR EARLY STAGE CHRONIC LYMP..:

Condoluci, A. ; Terzi di Bergamo, L. ; Langerbeins, P....
Hematological Oncology. 37 (2019) S2 - p. 81-82 , 2019

Link: https://doi.org/10.1002/..

11

Tu-P7:272 Matrix metalloproteinases and their inhibitor in ..:

Gasparetto, C. ; Culacciati, D. ; Malinverno, A...
Atherosclerosis Supplements. 7 (2006) 3 - p. 244 , 2006

Link: https://doi.org/10.1016/..

12

Different prognostic impact of recurrent gene mutations in ..:

Mansouri, L ; Thorvaldsdottir, B ; Sutton, L.A...
http://edoc.mdc-berlin.de/22996/1/22996oa.pdf. , 2023

Link: http://edoc.mdc-berlin.d..

13

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BA..:

M. C. Pirosa ; A. Bruscaggin ; L. Terzi di Bergamo...
http://journals.lww.com/10.1097/01.HS9.0000843792.32037.28. , 2022

Link: https://doi.org/10.1097/..

14

P1282: DISEASE-SPECIFIC U1 SPLICEOSOMAL RNA MUTATIONS IN MA..:

Nadeu, F ; Shuai, S ; Clot, G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429232/. , 2022

Link: http://www.ncbi.nlm.nih...

15

P1281: LIQUID BIOPSY PROVIDES COMPLEMENTARY INFORMATION TO ..:

Moia, R ; Favini, C ; Talotta, D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431283/. , 2022

Link: http://www.ncbi.nlm.nih...